TOP > 外国特許検索 > NERVOUS SYSTEM CELL POPULATION, NERVOUS SYSTEM CELL-CONTAINING PREPARATION AND METHOD FOR PRODUCING SAID POPULATION AND PREPARATION

NERVOUS SYSTEM CELL POPULATION, NERVOUS SYSTEM CELL-CONTAINING PREPARATION AND METHOD FOR PRODUCING SAID POPULATION AND PREPARATION NEW

外国特許コード F210010289
整理番号 (S2019-0467-N0)
掲載日 2021年1月28日
出願国 世界知的所有権機関(WIPO)
国際出願番号 2020JP019290
国際公開番号 WO 2020230856
国際出願日 令和2年5月14日(2020.5.14)
国際公開日 令和2年11月19日(2020.11.19)
優先権データ
  • 特願2019-091625 (2019.5.14) JP
発明の名称 (英語) NERVOUS SYSTEM CELL POPULATION, NERVOUS SYSTEM CELL-CONTAINING PREPARATION AND METHOD FOR PRODUCING SAID POPULATION AND PREPARATION NEW
発明の概要(英語) This disclosure pertains to a nervous system cell population, a nervous system cell-containing preparation, and a method for producing said population and preparation. In more detail, this invention pertains to a nervous system cell population derived from intraoral mesenchymal tissue cells having at least 80% of normal diploid cells, a preparation containing the same, and a method for producing said population and preparation.
従来技術、競合技術の概要(英語) BACKGROUND ART
Central nervous system injuries, especially spinal cord injuries, require nervous system cells to be transplanted within two weeks of the injury (NpL 1). On the other hand, although there are many reports of inducing differentiation from mesenchymal stem cells into neural cells, NpL 2 ~ 4) (, there is no report that cells that have been induced to differentiate into nerves have been isolated from ectodermal mesenchymal tissue in several days.
Furthermore, in order to obtain neural stem cells from tissues harvested from the patient itself, NpL 5 and NpL 1) must be separated using methods such as corona cloning or cell sorter. However, colognal cloning takes time, and a cell sorter requires expensive equipment and antibodies. furthermore, complicated operations such as antibody washing have been unavoidable. In addition, there has been a problem in that damage to neural stem cells is large during the separation process. In particular, in the case of autotransplantation in which the cell-containing preparation or regenerative medical material obtained by processing and manufacturing the cells harvested from the patient itself is transplanted into the same patient, if it takes time to induce differentiation from the cells harvested from the patient into neurons, there is a problem in that autotransplantation cannot respond to treatment in acute and sub-acute phases.
  • 出願人(英語)
  • ※2012年7月以前掲載分については米国以外のすべての指定国
  • UNIVERSITY OF TSUKUBA
  • 発明者(英語)
  • MARUSHIMA Aiki
  • MATSUMURA Akira
  • BUKAWA Hiroki
  • KODA Masao
  • ISHIKAWA Hiroshi
  • OHYAMA Akihiro
  • TOYOMURA Junko
  • MATSUMARU Yuji
  • MATSUMURA Hideaki
  • WATANABE Miho
国際特許分類(IPC)
指定国 National States: AE AG AL AM AO AT AU AZ BA BB BG BH BN BR BW BY BZ CA CH CL CN CO CR CU CZ DE DJ DK DM DO DZ EC EE EG ES FI GB GD GE GH GM GT HN HR HU ID IL IN IR IS JO JP KE KG KH KN KP KR KW KZ LA LC LK LR LS LU LY MA MD ME MG MK MN MW MX MY MZ NA NG NI NO NZ OM PA PE PG PH PL PT QA RO RS RU RW SA SC SD SE SG SK SL ST SV SY TH TJ TM TN TR TT TZ UA UG US UZ VC VN WS ZA ZM ZW
ARIPO: BW GH GM KE LR LS MW MZ NA RW SD SL SZ TZ UG ZM ZW
EAPO: AM AZ BY KG KZ RU TJ TM
EPO: AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
OAPI: BF BJ CF CG CI CM GA GN GQ GW KM ML MR NE SN ST TD TG
この特許について質問等ある場合は、電子メールによりご連絡ください。

PAGE TOP

close
close
close
close
close
close